CTKB R&D Expense Growth
Cytek Biosciences Inc · R&D Expense Growth
CTKB R&D Expense Growth
Latest reported1.43%period ending
CTKB Quarterly R&D Growth (QoQ) (0.00% → 1.43%)
Latest values, visible window
High-resolution chart · PNG
CTKB r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 1.4265% | |
| 7.1636% | |
| 0.067% | |
| 1.4729% | |
| -9.2442% | |
| 0.0206% | |
| -1.609% | |
| -1.1899% | |
| 2.0927% | |
| -9.8721% | |
| -2.7034% | |
| -7.9515% | |
| 21.6764% | |
| 2.3289% | |
| 12.6821% | |
| 2.5367% | |
| 5.1215% | |
| 13.4115% | |
| 16.4199% | |
| -1.8728% | |
| 21.594% | |
| 16.1688% | |
| 29.8874% | |
| 15.775% | |
| -3.3156% | |
| 0% |